| Assay Method Information | |
| | Inhibition of ALK IR Anaplastic Lymphoma Kinase Activity |
| Description: | To measure the activity of the N2-(2-methoxyphenyl)pyrimidine derivative represented by formula 1 of the present invention to inhibit anaplastic lymphoma kinase (ALK) activity at enzyme level, the following experiment was performed by the same manner as described in experimental example 1 except that IR (Insulin Receptor) protein was used instead of ALK WT protein. |
| Affinity data for this assay | |
|---|---|
| If you find an error in this entry please send us an E-mail | |